Axsome Therapeutics, Inc. (AXSM)
227.72
-4.55
(-1.96%)
USD |
NASDAQ |
May 15, 16:00
227.75
+0.03
(+0.01%)
After-Hours: 20:00
Axsome Therapeutics EPS Diluted (Quarterly) : -1.261 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | -1.715 |
| Indivior Pharmaceuticals, Inc. | 0.6899 |
| Eli Lilly & Co. | 8.255 |
| Esperion Therapeutics, Inc. | -0.1002 |
| Ocular Therapeutix, Inc. | -0.3954 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -64.54M |
| Revenue (Quarterly) | 191.20M |
| Total Expenses (Quarterly) | 255.74M |
| Enterprise Value | 11.63B |
| Gross Profit Margin (Quarterly) | 91.06% |
| Profit Margin (Quarterly) | -33.76% |
| Earnings Yield | -1.64% |
| Normalized Earnings Yield | -1.598 |